Citations

Showing 10 of 108094 citations.

Blockchain Technology: A Data Framework to Improve Validity, Trust, and Accountability of Information Exchange in Health Professions Education
Funk, E.E., Ankel, Felix , Cabrera, Daniel , Funk, Eric, Riddell, Jeff , Ankel, Felix , Cabrera, Daniel

Mayo Clinic

Academic Medicine | June 13, 2018 | Volume: 93 | Issue: 12 | Pages: 1791-1794

10.1097/acm.0000000000002326 | PMID 29901658 Get It

Health professions educators face multiple challenges, among them the need to adapt educational methods to new technologies. In the last decades, multiple new digital platforms have appeared in the learning arena, including massive open online courses and social-media-based education. The major critique of these novel methods is the lack of the ability to ascertain the origin, validity, and accountability of the knowledge that is created, shared, and acquired. Recently, a novel technology based on secured data storage and transmission, called blockchain, has emerged as a way to generate networks where validity, trust, and accountability can be created. Conceptually, blockchain is an open, public, distributed, and secure digital registry where information transactions are secured and have a clear origin, explicit pathways, and concrete value. Health professions education based on blockchain will potentially allow improved tracking of content and the individuals who create it, quantify educational impact on multiple generations of learners, and build a relative value of educational interventions. Furthermore, institutions adopting blockchain technology would be able to provide certification and credentialing of health care professionals with no intermediaries. There is potential for blockchain to significantly change the future of health professions education and radically transform how patients, professionals, educators, and learners interact around safe, valid, and accountable information.
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use
Zakroysky, Pearl, Xiang, Qun, Goldberg, Anne C. , Robinson, Jennifer G. , Roger, Véronique L. , Wilson, Peter W.F. , Elassal, Joseph, Lee, L. Veronica, Wang, Tracy Y., Nanna, Michael G. , Návar, Ann Marie , Virani, Salim S. , Peterson, Eric D.

Mayo Clinic

JAMA Cardiology | June 13, 2018 | Volume: 3 | Issue: 8 | Pages: 739

10.1001/jamacardio.2018.1511 | PMID 29898219 Get It

Physiology in Perspective: Physiology is Alive and Well
Sieck, Gary C.

Mayo Clinic

Physiology | June 13, 2018 | Volume: 33 | Issue: 4 | Pages: 252-253

10.1152/physiol.00022.2018 | PMID 29897301 Get It

Impaired β-cell glucokinase as an underlying mechanism in diet-induced diabetes
Lu, Brian , Kurmi, Kiran , Munoz-Gomez, Miguel, Jacobus, Egon J. , Tonne, Jason M., Rakshit, Kuntol, Hitosugi, Taro , Kudva, Yogish C. , Matveyenko, Aleksey V. , Ikeda, Yasuhiro , Jacobus Ambuludi, Egon J

Mayo Clinic

Disease Models & Mechanisms | June 13, 2018 | Volume: 11 | Issue: 6 | Pages: No page available

10.1242/dmm.033316 | PMID 29915142 Get It

ABSTRACT High-fat diet (HFD)-fed mouse models have been widely used to study early type 2 diabetes. Decreased β-cell glucokinase (GCK) expression has been observed in HFD-induced diabetes. However, owing to its crucial roles in glucose metabolism in the liver and in islet β-cells, the contribution of decreased GCK expression to the development of HFD-induced diabetes is unclear. Here, we employed a β-cell-targeted gene transfer vector and determined the impact of β-cell-specific increase in GCK expression on β-cell function and glucose handling in vitro and in vivo. Overexpression of GCK enhanced glycolytic flux, ATP-sensitive potassium channel activation and membrane depolarization, and increased proliferation in Min6 cells. β-cell-targeted GCK transduction did not change glucose handling in chow-fed C57BL/6 mice. Although adult mice fed a HFD showed reduced islet GCK expression, impaired glucose tolerance and decreased glucose-stimulated insulin secretion (GSIS), β-cell-targeted GCK transduction improved glucose tolerance and restored GSIS. Islet perifusion experiments verified restored GSIS in isolated HFD islets by GCK transduction. Thus, our data identify impaired β-cell GCK expression as an underlying mechanism for dysregulated β-cell function and glycemic control in HFD-induced diabetes. Our data also imply an etiological role of GCK in diet-induced diabetes. This article has an associated First Person interview with the first author of the paper.
Lower Fasted‐State but Greater Increase in Muscle Protein Synthesis in Response to Elevated Plasma Amino Acids in Obesity
Tran, Lee , Kras, Katon A., Hoffman, Nyssa, Ravichandran, Jayachandran , Dickinson, Jared M. , D’Lugos, Andrew C. , Carroll, Chad C. , Patel, Shivam H. , Mandarino, Lawrence J. , Roust, Lori R., Katsanos, Christos S. , Katsanos, Christos S , D'Lugos, Andrew C

Mayo Clinic

Obesity | June 13, 2018 | Volume: 26 | Issue: 7 | Pages: 1179-1187

10.1002/oby.22213 | PMID 29896930 Get It

ObjectiveObesity alters protein metabolism in skeletal muscle, but consistent evidence is lacking. This study compared muscle protein synthesis in adults with obesity and in lean controls in the fasted state and during an amino acid infusion.MethodsTen subjects with obesity (age: 36 ± 3 years; BMI: 34 ± 1 kg/m2) and ten controls (age: 35 ± 3 years; BMI: 23 ± 1 kg/m2) received an infusion of L‐[2,3,3,4,5,5,5,6,6,6‐2H10]leucine (0.15 μmol/kg fat‐free mass/min) to measure muscle protein synthesis after an overnight fast and during amino acid infusion.ResultsDespite greater muscle mammalian target of rapamycin phosphorylation (P ≤ 0.05), fasted‐state mixed‐muscle and mitochondrial protein synthesis were lower in subjects with obesity (P ≤ 0.05). However, the change in mixed‐muscle protein synthesis during the amino acid infusion was 2.7‐fold greater in subjects with obesity (P ≤ 0.05), accompanied by a greater change in S6 kinase‐1 phosphorylation (P ≤ 0.05). The change in mitochondrial protein synthesis did not differ between groups (P > 0.05).ConclusionsAdults with obesity have reduced muscle protein synthesis in the fasted state, but this response is compensated for by a greater change in overall muscle protein synthesis during amino acid infusion.
Readmissions After Complex Cancer Surgery: Analysis of the Nationwide Readmissions Database
Nembhard, Christine, Wilson, Lori , Habermann, Elizabeth B. , Raoof, Mustafa , Wasif, Nabil , Zafar, Syed Nabeel, Shah, Adil A. , Wilson, Lori L, Habermann, Elizabeth , Zafar, Syed Nabeel

Mayo Clinic

Journal of Oncology Practice | June 12, 2018 | Volume: 14 | Issue: 6 | Pages: e335-e345

10.1200/jop.17.00067 | PMID 29894662 Get It

Purpose: Hospital readmissions after surgery are a focus of quality improvement efforts. Although some reflect appropriate care, others are potentially preventable readmissions (PPRs). We aim to describe the burden, timing, and factors associated with readmissions after complex cancer surgery. Methods: The Nationwide Readmissions Database (2013) was used to select patients undergoing a complex oncologic resection, which was defined as esophagectomy/gastrectomy, hepatectomy, pancreatectomy, colorectal resection, lung resection, or cystectomy. Readmissions within 30 days from discharge were analyzed. International Classification of Diseases (9th revision) primary diagnosis codes were reviewed to identify PPRs. Multivariable logistic regression analyses identified demographic, clinical, and hospital factors associated with readmissions. Results: Of the 59,493 eligible patients, 14% experienced a 30-day readmission, and 82% of these were deemed PPRs. Half of the readmissions occurred within the first 8 days of discharge. Infections (26%), GI complications (17%), and respiratory conditions (10%) accounted for most readmissions. Factors independently associated with an increased likelihood of readmission included Medicaid versus private insurance (odds ratio [OR], 1.32; 95% CI, 1.17 to 1.48), higher comorbidity score (OR, 1.5; 95% CI, 1.33 to 1.63), discharge to a facility (OR, 1.39; 95% CI, 1.29 to 1.51), prolonged length of stay (OR, 1.42; 95% CI, 1.32 to 1.52), and occurrence of a major in-hospital complication (OR, 1.24; 95% CI, 1.16 to 1.34). Conclusion: One in seven patients undergoing complex cancer surgery suffered a readmission within 30 days. We identified common causes of these and identified patients at high risk for such an event. These data can be used by physicians, administrators, and policymakers to develop strategies to decrease readmissions.
Endobronchial Valves Therapy for Advanced Emphysema
Lee, Justin Z. , Desai, Hem , Hsu, Chiu‐Hsieh , Sam, Afshin, Knepler, James, Low, See‐Wei

Mayo Clinic

Journal of Bronchology & Interventional Pulmonology | June 12, 2018 | Volume: 26 | Issue: 2 | Pages: 81-89

10.1097/lbr.0000000000000527 | PMID 29901536 Get It

Background: Trials suggest that bronchoscopic lung volume reduction (BLVR) with endobronchial valve (EBV) implantation may produce similar effects as lung volume reduction surgery, by inducing atelectasis and reducing hyperinflation through a minimally invasive procedure. This study sought to investigate the efficacy and safety of BLVR with EBV for advanced emphysema. Methods: We searched PubMed, EMBASE, Web of Science, CINAHL, ClinicalTrials.gov, and Cochrane Library databases for randomized controlled trials comparing EBV implantation versus standard medical treatment or sham bronchoscopy. The main outcome of interest was the percentage change of forced expiratory volume in 1 second. Results: Data analyzed from 5 randomized controlled trials with 703 patients revealed improvement in percentage change of forced expiratory volume in 1 second in EBV group compared with control group [weighted mean difference (WMD)=11.43; 95% confidence interval (CI), 6.05-16.80; P<0.0001] and improvement in the St. George’s Respiratory Questionnaire score (WMD=−5.69; 95% CI, −8.67 to −2.70; P=0.0002). There is no difference shown in the 6-minute walking test (WMD=14.12; 95% CI, −4.71 to 32.95; P=0.14). The overall complication rate of EBV was not significantly different except for an increased rate of pneumothorax [relative risk (RR)=8.16; 95% CI, 2.21-30.11; P=0.002), any hemoptysis (RR=5.01; 95% CI, 1.12-22.49; P=0.04)] and valve migration (RR=8.64; 95% CI, 2.01-37.13; P=0.004). Conclusion: BLVR using EBV shows short-term improvement in lung function and quality of life, but with increased risk of minor hemoptysis, pneumothorax, and valve migration. Follow-up data on the studies are needed to determine its long-term efficacy.
Diagnostic Approach for Classic Compared With Localized Whipple Disease
Crews, Nicholas R. , Pritt, Bobbi S. , Patel, Robin , Virk, Abinash, Patel, Robin , Pritt, Bobbi S , Cawcutt, Kelly , Virk, Abinash

Mayo Clinic

Open Forum Infectious Diseases | June 12, 2018 | Volume: 5 | Issue: 7 | Pages: No page available

10.1093/ofid/ofy136 | PMID 29992176 Get It

Abstract Background Whipple disease (WD), a rare systemic infection caused by Tropheryma whipplei, can be a diagnostic challenge due to its variable presentation. The role of T. whipplei polymerase chain reaction (PCR) is unclear as small bowel biopsy with Periodic acid-Schiff (PAS) staining remains the diagnostic gold standard. Individualized diagnostic approaches based on variable clinical manifestations are underutilized. We investigated the methodologies employed at our institution to diagnose WD. Methods We retrospectively collected all cases of WD diagnosed from 1994 to 2016. Microbiology laboratory and anatomic pathology databases were queried. Case characteristics and disease clinical phenotypes (classical, localized WD arthritis, and localized central nervous system [CNS] disease) were described. The diagnostic approach and testing yield were analyzed and reported. Results Thirty-three cases of WD were diagnosed (18 classic WD [CWD], 9 localized WD arthritis [LWD], 6 CNS WD). Misdiagnosis and delay in diagnosis were frequent. Diagnostic approach and test yield differed by classical vs localized WD involvement. Small bowel tissue biopsy PAS stain/PCR was overwhelmingly positive (86%/92%) in CWD, yet seldom positive (12%/42%) in LWD (P &lt; .001). Affected joint synovial fluid PCR was frequently positive in both CWD (100%, 3/3) and LWD (85%, 6/7). Conclusions These results support the role of small bowel biopsy PAS stain/PCR in the diagnosis of CW, though this approach may be of limited utility in LWD or CNS WD without gastrointestinal symptoms. Affected joint synovial fluid or cerebrospinal fluid PCR was frequently positive in both CWD and LWD, supporting its diagnostic usefulness.
Complex Robotic Lower Urinary Tract Surgery in Patients with History of Open Surgery
Gargollo, Patricio C. , Granberg, Candace F. , Gong, Edward M. , Tu, Duong D. , DaJusta, Daniel , Granberg, Candace, Whittam, Benjamin M.

Mayo Clinic

Journal of Urology | June 12, 2018 | Volume: 201 | Issue: 1 | Pages: 162-168

10.1016/j.juro.2018.06.017 | PMID 29906433 Get It

Faculty Opinions recommendation of Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia.
Ansell, Stephen M.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 12, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.733362260.793546737 Get It